These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2629244)

  • 1. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of the diabetogenic factor in hypercoagulation of the blood].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Patol Fiziol Eksp Ter; 1986; (4):44-7. PubMed ID: 3797076
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recovery of the anticoagulation system function in patients with insulin-dependent diabetes by neutralization of the activity of diabetogenic factor].
    Kudriashov BA; Balabolkin MI; Ul'ianov AM; Liapina LA; Levitskaia ZI
    Vopr Med Khim; 1990; 36(3):79-81. PubMed ID: 2382439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural diabetogenic factor].
    Kudriashov BA
    Sov Med; 1989; (7):51-4. PubMed ID: 2678523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes].
    Kudriashov BA; Ul'ianov AM
    Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dependence of the blood plasma activity of the diabetogenic factor in animals on the functional depression of the anticoagulating system induced by an atherogenic diet].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (2):50-3. PubMed ID: 3697425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the protein isolated from a blood albumin fraction in normal states and in diabetes].
    Liapina LA; Kudriashov BA; Baratova LA
    Vopr Med Khim; 1987; 33(6):69-71. PubMed ID: 3445550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decreased sensitivity to the hypoglycemic action of insulin in animals with a lowered blood heparin concentration].
    Ul'ianov AM; Shapiro FB; Bazaz'ian GG
    Biull Eksp Biol Med; 1987 May; 103(5):522-4. PubMed ID: 3297185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetogenic factor in the blood plasma in diabetes mellitus].
    Kudriashov BA; Ponasenkova GV; Pytel' IuA
    Probl Endokrinol (Mosk); 1982; 28(5):61-4. PubMed ID: 7145885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensification of the diabetogenic effect of alloxan by protamine sulfate].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(4):128-31. PubMed ID: 2815670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the pancreas in the appearance of the diabetogenic factor during the development of alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1989; (3):75-9. PubMed ID: 2797907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidiabetogenic action of heparin during its oral administration].
    Ul'ianov AM; Tarasov IuA
    Patol Fiziol Eksp Ter; 1996; (1):21-3. PubMed ID: 8657446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of an increased protein and fat content in the food ration of rats for the development of stable alloxan diabetes].
    Ul'ianov AM; Tarasov IuA
    Probl Endokrinol (Mosk); 1989; 35(6):78-81. PubMed ID: 2622891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of blood coagulation in experimental diabetes.
    Roy AK; Srivastava GN; Mukherjee SK; Sharma KM
    Acta Biol Med Ger; 1978; 37(8):1301-3. PubMed ID: 749466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes].
    Baskakova GM; Kudriashov BA; Pytel' IuA
    Probl Endokrinol (Mosk); 1981; 27(4):42-5. PubMed ID: 7027248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pancreas as a source of natural diabetogenic factor in alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1991; (2):46-7. PubMed ID: 1881712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.